Logo image of TALK

TALKSPACE INC (TALK) Stock Fundamental Analysis

USA - NASDAQ:TALK - US87427V1035 - Common Stock

3.25 USD
+0.02 (+0.62%)
Last: 11/14/2025, 8:00:01 PM
3.2 USD
-0.05 (-1.54%)
After Hours: 11/14/2025, 8:00:01 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TALK. TALK was compared to 100 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for TALK as it has an excellent financial health rating, but there are worries on the profitability. TALK shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TALK had positive earnings in the past year.
In the past year TALK had a positive cash flow from operations.
In the past 5 years TALK reported 4 times negative net income.
TALK had negative operating cash flow in 4 of the past 5 years.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

With a decent Return On Assets value of 3.29%, TALK is doing good in the industry, outperforming 65.00% of the companies in the same industry.
With a Return On Equity value of 3.89%, TALK perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
ROA 3.29%
ROE 3.89%
ROIC N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

TALK has a Profit Margin of 1.98%. This is comparable to the rest of the industry: TALK outperforms 60.00% of its industry peers.
TALK has a better Gross Margin (43.27%) than 71.00% of its industry peers.
TALK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.98%
GM 43.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

TALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TALK has more shares outstanding
The number of shares outstanding for TALK has been increased compared to 5 years ago.
There is no outstanding debt for TALK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

TALK has an Altman-Z score of 16.02. This indicates that TALK is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 16.02, TALK belongs to the top of the industry, outperforming 97.00% of the companies in the same industry.
There is no outstanding debt for TALK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.02
ROIC/WACCN/A
WACC9.13%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 5.91 indicates that TALK has no problem at all paying its short term obligations.
TALK has a Current ratio of 5.91. This is amongst the best in the industry. TALK outperforms 94.00% of its industry peers.
TALK has a Quick Ratio of 5.91. This indicates that TALK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.91, TALK belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.91
Quick Ratio 5.91
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 400.00% over the past year.
TALK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.37%.
The Revenue has been growing by 37.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%25.28%

3.2 Future

TALK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 158.83% yearly.
TALK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.05% yearly.
EPS Next Y274.03%
EPS Next 2Y232.41%
EPS Next 3Y158.83%
EPS Next 5YN/A
Revenue Next Year20.61%
Revenue Next 2Y21.49%
Revenue Next 3Y20.44%
Revenue Next 5Y21.05%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 108.33 indicates a quite expensive valuation of TALK.
TALK's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of TALK to the average of the S&P500 Index (25.89), we can say TALK is valued expensively.
The Price/Forward Earnings ratio is 29.41, which means the current valuation is very expensive for TALK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TALK is on the same level as its industry peers.
TALK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 34.59.
Industry RankSector Rank
PE 108.33
Fwd PE 29.41
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TALK is valued a bit more expensive than 66.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 186.05
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TALK's earnings are expected to grow with 158.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y232.41%
EPS Next 3Y158.83%

More info and screens

0

5. Dividend

5.1 Amount

TALK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TALKSPACE INC

NASDAQ:TALK (11/14/2025, 8:00:01 PM)

After market: 3.2 -0.05 (-1.54%)

3.25

+0.02 (+0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-18 2026-02-18/amc
Inst Owners59.77%
Inst Owner Change0.33%
Ins Owners3.93%
Ins Owner Change-1.03%
Market Cap544.28M
Revenue(TTM)214.59M
Net Income(TTM)4.24M
Analysts81.54
Price Target4.9 (50.77%)
Short Float %3.65%
Short Ratio4.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-46.51%
Min EPS beat(2)-100%
Max EPS beat(2)6.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.48%
Min Revenue beat(2)-0.33%
Max Revenue beat(2)1.3%
Revenue beat(4)1
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)1.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.04%
Revenue beat(12)7
Avg Revenue beat(12)1.38%
Revenue beat(16)8
Avg Revenue beat(16)0.5%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-7.71%
EPS NQ rev (3m)11.11%
EPS NY rev (1m)-8.32%
EPS NY rev (3m)-18.51%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)3.35%
Revenue NY rev (1m)1.13%
Revenue NY rev (3m)1.44%
Valuation
Industry RankSector Rank
PE 108.33
Fwd PE 29.41
P/S 2.54
P/FCF N/A
P/OCF 75.19
P/B 4.99
P/tB 4.99
EV/EBITDA 186.05
EPS(TTM)0.03
EY0.92%
EPS(NY)0.11
Fwd EY3.4%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.04
OCFY1.33%
SpS1.28
BVpS0.65
TBVpS0.65
PEG (NY)0.4
PEG (5Y)N/A
Graham Number0.66
Profitability
Industry RankSector Rank
ROA 3.29%
ROE 3.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.98%
GM 43.27%
FCFM N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
F-Score7
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 395.89%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion 336.23%
Profit Quality N/A
Current Ratio 5.91
Quick Ratio 5.91
Altman-Z 16.02
F-Score7
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)224%
Cap/Depr(5y)197.42%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y274.03%
EPS Next 2Y232.41%
EPS Next 3Y158.83%
EPS Next 5YN/A
Revenue 1Y (TTM)18.37%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%25.28%
Revenue Next Year20.61%
Revenue Next 2Y21.49%
Revenue Next 3Y20.44%
Revenue Next 5Y21.05%
EBIT growth 1Y98.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year450.73%
EBIT Next 3Y135.19%
EBIT Next 5Y109.41%
FCF growth 1Y94.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.89%
OCF growth 3YN/A
OCF growth 5YN/A

TALKSPACE INC / TALK FAQ

What is the fundamental rating for TALK stock?

ChartMill assigns a fundamental rating of 5 / 10 to TALK.


What is the valuation status for TALK stock?

ChartMill assigns a valuation rating of 3 / 10 to TALKSPACE INC (TALK). This can be considered as Overvalued.


What is the profitability of TALK stock?

TALKSPACE INC (TALK) has a profitability rating of 2 / 10.


How financially healthy is TALKSPACE INC?

The financial health rating of TALKSPACE INC (TALK) is 8 / 10.


Can you provide the expected EPS growth for TALK stock?

The Earnings per Share (EPS) of TALKSPACE INC (TALK) is expected to grow by 274.03% in the next year.